CNE100002WP3
CNE100002WP3
NANJING KING-FRIEND BIOCHEMICAL
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 |
|---|---|---|---|
Market & Enterprise Value | |||
Market Cap | 13.22B EUR | 11.42B EUR | 15.82B EUR |
Enterprise Value | 12.55B EUR | 11.8B EUR | 16.22B EUR |
Valuation Multiples | |||
Trailing P/E | 27.27x | 21.11x | 29.99x |
Forward P/E | 19.48x | -- | -- |
Price to Sales | 3.36x | 2.8x | 3.98x |
Price to Book | 1.94x | 1.65x | 2.26x |
EV/Revenue | 3.19x | 2.89x | 4.08x |
EV/EBITDA | 15.24x | 25.94x | 33.63x |
Price to FCF (P/FCF) | 12.9x | 14.52x | 25.37x |
EV/FCF | 12.25x | 15x | 26.02x |
FCF Yield | 7.75% | 6.89% | 3.94% |